Presence of chemotherapy-induced toxicity predicts improved survival in patients with localised extremity osteosarcoma treated with doxorubicin and cisplatin: A report from the European Osteosarcoma Intergroup

Author(s):
McTiernan, A.; Jinks, R.C.; Sydes, M.R.; Uscinska, B.; Hook, J.M.; Glabbeke, M. van; Bramwell, V.; Lewis, I.J.; Taminiau, A.H.M.; Nooij, M.A.; Hogendoorn, P.C.W. (0000-0002-1513-8104); Gelderblom, H.; Whelan, J.S.
Published
2012
Publication type
Article / Letter to editor
OsteosarcomaToxicitySurvivalChemotherapy
Date issued
2012-03-31
Language
English
Is part of
European Journal of Cancer (2012), Vol. 48, no. 5, p. 703-712
hdl
1887/96698
doi
10.1016/j.ejca.2011.09.012